BioTech finances

Independent Ranking Shows More Transparency, More Programs for
Low-income Countries

 European pharmaceutical companies out compete their U.S. counterparts in
making medicines available to people in developing countries, but their lead
is shrinking, according to the second Access to Medicine Index, released
today.